Pharmaceuticals News and Research

RSS

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, announced today the publication of preclinical data on ATSP-7041, a potent and selective stapled peptide re-activator of the wild type p53 tumor suppressor protein.

17 Aug 2013

Novel way of observing electrical response in brain before and during fall through EEG

It's always in front of a million people and feels like eternity. You're strolling along when suddenly you've stumbled-the brain realizes you're falling, but your muscles aren't doing anything to stop it.

17 Aug 2013

Scientists develop new therapies to prevent chemoresistance of established tumours

Cancer cells often develop defence mechanisms which enable them to survive chemotherapy. A group of researchers from the Institutes of Pharmacology and Pathology in Bern present new solutions for preventing the development of such resistances.

17 Aug 2013

New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

The Life Sciences Division of Hitachi High Technologies America, Inc. released its newest UV-visible spectrophotometer, Model UH5300.

16 Aug 2013

New chemotherapy provides positive outcomes for hard-to-treat childhood cancers with few side-effects

Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).

16 Aug 2013

In efforts to implement the health law, delays stack up

Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.

16 Aug 2013

Researchers develop new method that creates libraries of drug candidates, accelerate drug discovery

James Bond had his reasons for ordering his martinis "shaken, not stirred." Similarly, drug manufacturers need to make sure the molecules in a new drug are arranged in an exact manner, lest there be dire consequences. Specifically, they need to be wary of enantiomers, mirror-image molecules composed of the same atoms, but arranged differently.

16 Aug 2013

ASH announces 12 recipients of its second round of ASH Bridge Grants

As federal funding cuts continue to jeopardize the progress of biomedical research, the American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today announced the 12 recipients of its second round of ASH Bridge Grants.

16 Aug 2013

Sugar offers noninvasive way to precisely image tumors through new imaging technology

A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.

16 Aug 2013

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.

15 Aug 2013

Sanford-Burnham, Pfizer collaborates to identify therapeutic targets for treating obesity, diabetes

Sanford-Burnham Medical Research Institute (Sanford-Burnham) announced that it has entered into a collaboration with Pfizer Inc. to identify new therapeutic targets for preventing and treating complications of obesity and diabetes.

14 Aug 2013

New test hints 3 sodas daily hurt lifespan, reproduction in mice

When mice ate a diet of 25 percent extra sugar - the mouse equivalent of a healthy human diet plus three cans of soda daily - females died at twice the normal rate and males were a quarter less likely to hold territory and reproduce, according to a toxicity test developed at the University of Utah.

14 Aug 2013

Intercept Pharmaceuticals reports financial results for Second quarter 2013

Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences.

13 Aug 2013

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Teva Pharmaceutical Industries Ltd. and Perrigo Company today announced the launch of the generic equivalent to Temodar (temozolomide).

13 Aug 2013

Nuevolution forms scientific collaboration to investigate biological mechanism of GPCR drug target

Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a specified GPCR drug target.

13 Aug 2013

Breastfeeding linked with decreased risk of obesity among kids in Japan

Breastfeeding appears to be associated with decreased risk of overweight and obesity among school children in Japan, according to a study by Michiyo Yamakawa, M.H.Sc., of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama City, Japan, and colleagues.

13 Aug 2013

Derma Sciences reports financial and operating results for 2013

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2013.

12 Aug 2013

Omeros announces financial results for second quarter of 2013

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

12 Aug 2013

Saint Luke's Heart Institute seeks talented individuals for postdoctoral cardiovascular research

Saint Luke's Mid America Heart Institute—one of the leading outcomes research centers in the nation—is seeking highly motivated, talented individuals for its two-year postdoctoral training program in cardiovascular outcomes research.

12 Aug 2013

Brand-name and generic drug makers take fight to states

The battle concerns state notification laws that would require pharmacists to notify doctors and patients when they substitute generic versions of drugs derived from living organisms known as biologics.

12 Aug 2013

Pharmaceuticals News and Research

ATSP-7041 stapled peptide activates p53, suppresses tumor growth in animal models

Novel way of observing electrical response in brain before and during fall through EEG

Scientists develop new therapies to prevent chemoresistance of established tumours

New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

New chemotherapy provides positive outcomes for hard-to-treat childhood cancers with few side-effects

In efforts to implement the health law, delays stack up

Researchers develop new method that creates libraries of drug candidates, accelerate drug discovery

ASH announces 12 recipients of its second round of ASH Bridge Grants

Sugar offers noninvasive way to precisely image tumors through new imaging technology

Boehringer Ingelheim completes patient enrolment of two pivotal Phase III interferon-free hepatitis C clinical trials

Sanford-Burnham, Pfizer collaborates to identify therapeutic targets for treating obesity, diabetes

New test hints 3 sodas daily hurt lifespan, reproduction in mice

Intercept Pharmaceuticals reports financial results for Second quarter 2013

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Nuevolution forms scientific collaboration to investigate biological mechanism of GPCR drug target

Breastfeeding linked with decreased risk of obesity among kids in Japan

Derma Sciences reports financial and operating results for 2013

Omeros announces financial results for second quarter of 2013

Saint Luke's Heart Institute seeks talented individuals for postdoctoral cardiovascular research

Brand-name and generic drug makers take fight to states

Event guide: World ADC London eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence